Although the C921Y substitution was shown to reduce OGT VMAXin vitro to 25% of the WT [82], these mutant mice do not show embryonic sub-lethality, but present features shared with XLID human patients, making this model very well suited to study XLID’s pathology [83]. Here, OGT is linked to cask-related x-linked intellectual disability.